Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Consequently, many GSH-responsive nanoplatforms are designed either to deplete GSH by targeting these pathways or to exploit high GSH levels as triggers for selective drug release
Tissue Cell
10.1093/emboj/cdg393 49
Moreover, overlapping pathological features exist for diabetes, IR, and AD
Filomeni and Ciriolo, 2006), and downstream targets (mitochondrial and cytoskeleton proteins)
Pinnen F, Cacciatore I, Cornacchia C, Sozio P, Iannitelli A, Costa M, et al
US$ 20.64
US$ 21.13
US$ 28.21
US$ 20.47
US$ 26.89
US$ 23.23
%20powder-1.png)
US$ 20.46
US$ 23.54
US$ 26.51
